Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on February 1, 2017, with the earliest event reported on that same date. The filing addresses a regulatory matter concerning the listing status of the Company's common stock on The NASDAQ Global Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The only quantitative metric disclosed is the Market Value of Publicly Held Shares (MVPHS), which reached or exceeded $5,000,000.
Material Changes
The primary material event is the resolution of a listing deficiency. On January 11, 2017, the Company received notice from Nasdaq that it failed to maintain the required minimum MVPHS of $5,000,000. The Company was granted 180 days to regain compliance. As of February 1, 2017, the Company confirmed it has regained compliance because its MVPHS closed at $5,000,000 or greater for 10 consecutive business days (January 17 through January 31, 2017).
Outlook, Risks, and Management Commentary
Management reports that the matter regarding the Nasdaq listing deficiency is now closed. No forward-looking guidance, new risks, contingencies, or unusual items are disclosed in this specific filing.
Key Facts for Investor Verification
- The Company has successfully regained compliance with Nasdaq Listing Rule 5450(b)(1)(C).
- The compliance was achieved by maintaining an MVPHS of at least $5,000,000 for 10 consecutive trading days ending January 31, 2017.
- The 180-day compliance period originally granted on January 11, 2017, is no longer active as the issue is resolved.
- This filing contains no financial performance data; investors should refer to the Company's most recent 10-K or 10-Q for financial metrics.